Last 12 months
Inside the activity.
12 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 10 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 23, 2020 Filed Jul 27, 2020 16:42 UTC |
Wang Theodore TDirector · 10% owner
Puissance Capital Fund (GP) LLC10% owner
Puissance Capital Management LP10% owner
|
GrantCommon Stock | 7,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043737 · doc4.xml · nonDerivative · entry 1 Wang Theodore T · CIK 0001694061 · Director · 10% owner Puissance Cross-Border Opportunities II LLC · CIK 0001717781 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,958 F1 · price: The grant consists of RSUs that fully vest one year from the date of grant, or July 23, 2021. F2 · balance_after: After taking into account the 1-for-15 reverse stock split effective March 24, 2020. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 16:31 UTC |
Stern StanleyDirector
|
GrantCommon Stock | 7,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043729 · doc4.xml · nonDerivative · entry 1 Stern Stanley · CIK 0001316499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,235 F1 · price: The grant consists of RSUs that fully vest one year from the date of grant, or July 23, 2021. F2 · balance_after: After taking into account the 1-for-15 reverse stock split effective March 24, 2020. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:27 UTC |
Li KechengDirector
|
GrantCommon Stock | 7,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043725 · doc4.xml · nonDerivative · entry 1 Li Kecheng · CIK 0001735083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,143 F1 · price: The grant consists of RSUs that fully vest one year from the date of grant, or July 23, 2021. F2 · balance_after: After taking into account the 1-for-15 reverse stock split effective March 24, 2020. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:24 UTC |
Hamilton MarilynDirector
|
GrantCommon Stock | 7,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043723 · doc4.xml · nonDerivative · entry 1 Hamilton Marilyn · CIK 0001640203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,770 F1 · price: The grant consists of RSUs that fully vest one year from the date of grant, or July 23, 2021. F2 · balance_after: After taking into account the 1-for-15 reverse stock split effective March 24, 2020. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 16:56 UTC |
Jones Jason CVP of Product Development
|
GrantCommon Stock | 8,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-022651 · doc4.xml · nonDerivative · entry 1 Jones Jason C · CIK 0001775619 · VP of Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,872 F1 · date: The grant of the RSUs was approved by the compensation committee of the company's board of directors on November 6, 2019 contingent upon (a) approval by the company's stockholders at the next occurring special or annual meeting of the stockholders (to increase the number of shares reserved for issuance under the company's Amended and Restated 2014 Equity Incentive Plan to accommodate the grants of the RSUs), which approval was obtained at a special meeting of the stockholders on March 12, 2020, and (b) the company filing a registration statement on Form S-8 with the Securities and Exchange Commission (the "SEC") to register the offer and sale of the shares underlying the RSUs, which registration statement was filed with the SEC on April 1, 2020. F2 · price: The grant consists of restricted stock units ("RSUs") that vest as to one quarter (1/4th) of the total number listed above on November 15, 2020, and as to an additional one quarter (1/4th) of the total number of RSUs listed above on November 15 of each following year. F3 · balance_after: After taking into account the 1-for-15 reverse stock split effective March 24, 2020. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:54 UTC |
GLENN JOHNChief Financial Officer
|
GrantCommon Stock | 10,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-022637 · doc4.xml · nonDerivative · entry 1 GLENN JOHN · CIK 0001253497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,981 F1 · date: The grant of the RSUs was approved by the compensation committee of the company's board of directors on November 6, 2019 contingent upon (a) approval by the company's stockholders at the next occurring special or annual meeting of the stockholders (to increase the number of shares reserved for issuance under the company's Amended and Restated 2014 Equity Incentive Plan to accommodate the grants of the RSUs), which approval was obtained at a special meeting of the stockholders on March 12, 2020, and (b) the company filing a registration statement on Form S-8 with the Securities and Exchange Commission (the "SEC") to register the offer and sale of the shares underlying the RSUs, which registration statement was filed with the SEC on April 1, 2020. F2 · price: The grant consists of restricted stock units ("RSUs") that vest as to one quarter (1/4th) of the total number listed above on November 15, 2020, and as to an additional one quarter (1/4th) of the total number of RSUs listed above on November 15 of each following year. F3 · balance_after: After taking into account the 1-for-15 reverse stock split effective March 24, 2020. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 21:03 UTC |
Shaw William RChief Commercial Officer
|
GrantCommon Stock | 13,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-022676 · doc4.xml · nonDerivative · entry 1 Shaw William R · CIK 0001776374 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 F1 · date: The grant of the RSUs was approved by the compensation committee of the company's board of directors on November 6, 2019 contingent upon (a) approval by the company's stockholders at the next occurring special or annual meeting of the stockholders (to increase the number of shares reserved for issuance under the company's Amended and Restated 2014 Equity Incentive Plan to accommodate the grants of the RSUs), which approval was obtained at a special meeting of the stockholders on March 12, 2020, and (b) the company filing a registration statement on Form S-8 with the Securities and Exchange Commission (the "SEC") to register the offer and sale of the shares underlying the RSUs, which registration statement was filed with the SEC on April 1, 2020. F2 · price: The grant consists of restricted stock units ("RSUs") that vest as to one quarter (1/4th) of the total number listed above on November 15, 2020, and as to an additional one quarter (1/4th) of the total number of RSUs listed above on November 15 of each following year. F3 · balance_after: After taking into account the 1-for-15 reverse stock split effective March 24, 2020. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 21:00 UTC |
Peurach JackDirector · Chief Executive Officer
|
GrantCommon Stock | 35,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-022669 · doc4.xml · nonDerivative · entry 1 Peurach Jack · CIK 0001640206 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,542 F1 · date: The grant of the RSUs was approved by the compensation committee of the company's board of directors on November 6, 2019 contingent upon (a) approval by the company's stockholders at the next occurring special or annual meeting of the stockholders (to increase the number of shares reserved for issuance under the company's Amended and Restated 2014 Equity Incentive Plan to accommodate the grants of the RSUs), which approval was obtained at a special meeting of the stockholders on March 12, 2020, and (b) the company filing a registration statement on Form S-8 with the Securities and Exchange Commission (the "SEC") to register the offer and sale of the shares underlying the RSUs, which registration statement was filed with the SEC on April 1, 2020. F2 · price: The grant consists of restricted stock units ("RSUs") that vest as to one quarter (1/4th) of the total number listed above on November 15, 2020, and as to an additional one quarter (1/4th) of the total number of RSUs listed above on November 15 of each following year. F3 · balance_after: After taking into account the 1-for-15 reverse stock split effective March 24, 2020. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:42 UTC |
Wang Theodore TDirector · 10% owner
Puissance Capital Fund (GP) LLC10% owner
Puissance Capital Management LP10% owner
|
OtherCommon Stock | 8,918,898 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001717781-20-000001 · primary_doc.xml · nonDerivative · entry 1 Wang Theodore T · CIK 0001694061 · Director · 10% owner Puissance Cross-Border Opportunities II LLC · CIK 0001717781 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Puissance Cross-Border Opportunities II LLC Disclosed balance after: 11,616,000 F1 · kind: Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 8,918,898 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests. F1 · price: Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 8,918,898 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests. F2 · ownership.direct: These securities are held directly by Puissance Cross-Border Opportunities II LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities II LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities II LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 16:35 UTC |
SCHRECK THOMAS ADirector
|
GrantStock Option (right to buy) · Derivative | 136,496 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-20-004272 · doc4.xml · derivative · entry 2 SCHRECK THOMAS A · CIK 0001134622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,496 Underlying: Common Stock · 136,496 shares Expires 2030-01-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of July 1, 2019. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 16:35 UTC |
SCHRECK THOMAS ADirector
|
GrantCommon Stock | 34,723 | $0.45 | $15,625.35 |
DisclosureSEC source: 0001209191-20-004272 · doc4.xml · nonDerivative · entry 1 SCHRECK THOMAS A · CIK 0001134622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,723 Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 20:58 UTC |
Wang Theodore TDirector · 10% owner
Puissance Capital Fund (GP) LLC10% owner
Puissance Capital Management LP10% owner
|
GrantStock Option (right to buy) · Derivative | 136,496 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-20-004378 · doc4.xml · derivative · entry 3 Wang Theodore T · CIK 0001694061 · Director · 10% owner Puissance Cross-Border Opportunities II LLC · CIK 0001717781 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,496 Underlying: Common Stock · 136,496 shares Expires 2030-01-16 F2 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of July 1, 2019. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 20:58 UTC |
Wang Theodore TDirector · 10% owner
Puissance Capital Fund (GP) LLC10% owner
Puissance Capital Management LP10% owner
|
GrantCommon Stock | 19,445 | $0.45 | $8,750.25 |
DisclosureSEC source: 0001209191-20-004378 · doc4.xml · nonDerivative · entry 1 Wang Theodore T · CIK 0001694061 · Director · 10% owner Puissance Cross-Border Opportunities II LLC · CIK 0001717781 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,624 Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 17:40 UTC |
Stern StanleyDirector
|
GrantStock Option (right to buy) · Derivative | 136,496 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-20-004315 · doc4.xml · derivative · entry 2 Stern Stanley · CIK 0001316499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,496 Underlying: Common Stock · 136,496 shares Expires 2030-01-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of July 1, 2019. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 17:40 UTC |
Stern StanleyDirector
|
GrantCommon Stock | 27,778 | $0.45 | $12,500.10 |
DisclosureSEC source: 0001209191-20-004315 · doc4.xml · nonDerivative · entry 1 Stern Stanley · CIK 0001316499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,778 Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 16:37 UTC |
SHERMAN STEVENDirector · Executive Chairman
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-20-004275 · doc4.xml · derivative · entry 2 SHERMAN STEVEN · CIK 0001201619 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2030-01-16 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 31,250 shares on March 31, 2020, and as to a further 31,250 shares on the last day of each third month thereafter. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 16:37 UTC |
SHERMAN STEVENDirector · Executive Chairman
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004275 · doc4.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,825 F1 · security: Granted as restricted stock units ("RSUs"). The RSUs vest as to 25,000 shares on March 31, 2020 and the last day of each third month thereafter, and settle upon the reporting person's termination of service with the Company. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 21:39 UTC |
Hamilton MarilynDirector
|
GrantStock Option (right to buy) · Derivative | 136,496 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-20-004278 · doc4.xml · derivative · entry 2 Hamilton Marilyn · CIK 0001640203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,496 Underlying: Common Stock · 136,496 shares Expires 2030-01-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of July 1, 2019. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 21:39 UTC |
Hamilton MarilynDirector
|
GrantCommon Stock | 22,223 | $0.45 | $10,000.35 |
DisclosureSEC source: 0001209191-20-004278 · doc4.xml · nonDerivative · entry 1 Hamilton Marilyn · CIK 0001640203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,795 Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 21:33 UTC |
Li KechengDirector
|
GrantStock Option (right to buy) · Derivative | 136,496 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-20-004268 · doc4.xml · derivative · entry 2 Li Kecheng · CIK 0001735083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,496 Underlying: Common Stock · 136,496 shares Expires 2030-01-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of July 1, 2019. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 21:33 UTC |
Li KechengDirector
|
GrantCommon Stock | 26,389 | $0.45 | $11,875.05 |
DisclosureSEC source: 0001209191-20-004268 · doc4.xml · nonDerivative · entry 1 Li Kecheng · CIK 0001735083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,389 Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 18:04 UTC |
Jones Jason CVP of Product Development
|
GrantEmployee Stock Option (right to buy) · Derivative | 190,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-19-055864 · doc4.xml · derivative · entry 1 Jones Jason C · CIK 0001775619 · VP of Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,000 Underlying: Common Stock · 190,000 shares Expires 2029-11-06 F1 · derivative.exercise_date: The option becomes exercisable as to 1/48th of the total number of shares on December 6, 2019 and thereafter as to 1/48th of the total number of shares on the same day of each month. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 23:03 UTC |
GLENN JOHNChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 240,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-19-055863 · doc4.xml · derivative · entry 1 GLENN JOHN · CIK 0001253497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,000 Underlying: Common Stock · 240,000 shares Expires 2029-11-06 F1 · derivative.exercise_date: The option becomes exercisable as to 1/48th of the total number of shares on December 6, 2019 and thereafter as to 1/48th of the total number of shares on the same day of each month. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 23:06 UTC |
Shaw William RChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 290,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-19-055867 · doc4.xml · derivative · entry 1 Shaw William R · CIK 0001776374 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 770,000 Underlying: Common Stock · 290,000 shares Expires 2029-11-06 F1 · derivative.exercise_date: The option becomes exercisable as to 1/48th of the total number of shares on December 6, 2019 and thereafter as to 1/48th of the total number of shares on the same day of each month. Read SEC document |
| November 06, 2019 Filed Nov 8, 2019 23:05 UTC |
Peurach JackDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 795,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001209191-19-055865 · doc4.xml · derivative · entry 1 Peurach Jack · CIK 0001640206 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,545,000 Underlying: Common Stock · 795,000 shares Expires 2029-11-06 F1 · derivative.exercise_date: The option becomes exercisable as to 1/48th of the total number of shares on December 6, 2019 and thereafter as to 1/48th of the total number of shares on the same day of each month. Read SEC document |
| May 31, 2019 Filed Jun 19, 2019 13:53 UTC |
Jones Jason CVP of Product Development
|
SaleCommon Stock | 9,430 | $1.31 | $12,353.30 |
DisclosureSEC source: 0001209191-19-037948 · doc4.xml · nonDerivative · entry 1 Jones Jason C · CIK 0001775619 · VP of Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,070 F1 · shares: The shares were sold by the filer to satisfy the tax obligations of the filer in connection with a grant of common stock on April 24, 2019 in lieu of cash payment of bonus for services performed in 2018. Read SEC document |
| May 31, 2019 Filed Jun 19, 2019 17:48 UTC |
GLENN JOHNChief Financial Officer
|
SaleCommon Stock | 10,292 | $1.37 | $14,100.04 |
DisclosureSEC source: 0001209191-19-037946 · doc4.xml · nonDerivative · entry 1 GLENN JOHN · CIK 0001253497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,708 F1 · shares: The shares were sold by the filer to satisfy the tax obligations of the filer in connection with a grant of common stock on April 24, 2019 in lieu of cash payment of bonus for services performed in 2018. Read SEC document |
| May 31, 2019 Filed Jun 19, 2019 17:56 UTC |
Peurach JackDirector · Chief Executive Officer
|
SaleCommon Stock | 31,437 | $1.37 | $43,068.69 |
DisclosureSEC source: 0001209191-19-037950 · doc4.xml · nonDerivative · entry 1 Peurach Jack · CIK 0001640206 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,120 F1 · shares: The shares were sold by the filer to satisfy the tax obligations of the filer in connection with a grant of common stock on April 24, 2019 in lieu of cash payment of bonus for services performed in 2018. Read SEC document |
| May 29, 2019 Filed May 31, 2019 18:08 UTC |
Shaw William RChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 480,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001209191-19-033591 · doc4.xml · derivative · entry 1 Shaw William R · CIK 0001776374 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,000 Underlying: Common Stock · 480,000 shares Expires 2029-05-29 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 120,000 shares on May 6, 2020, and the remaining shares will vest and become exercisable in 36 equal monthly installments thereafter. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 21:11 UTC |
GLENN JOHNChief Financial Officer
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-026248 · doc4.xml · nonDerivative · entry 1 GLENN JOHN · CIK 0001253497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · shares: The shares were awarded in lieu of cash payment of bonus for services performed as an executive officer in 2018. Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 21:28 UTC |
Peurach JackDirector · Chief Executive Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-026276 · doc4.xml · nonDerivative · entry 1 Peurach Jack · CIK 0001640206 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,557 F1 · shares: The shares were awarded in lieu of cash payment of bonus for services performed as an executive officer in 2018. Read SEC document |
| November 01, 2018 Filed Nov 5, 2018 17:20 UTC |
SCHRECK THOMAS ADirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,750 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001209191-18-057248 · doc4.xml · derivative · entry 1 SCHRECK THOMAS A · CIK 0001134622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,750 Underlying: Common Stock · 30,750 shares Expires 2028-11-01 F1 · derivative.exercise_date: The option vests and becomes exercisable in 9 equal monthly installments beginning on November 30, 2018. Read SEC document |
| November 01, 2018 Filed Nov 5, 2018 17:40 UTC |
SHERMAN STEVENDirector · Executive Chairman
|
GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001209191-18-057259 · doc4.xml · derivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2028-11-01 F1 · derivative.exercise_date: The option will become exercisable as to 50,000 shares on January 30, 2019, and as to a further 50,000 shares on the 30th day of each third month thereafter. Read SEC document |
| August 31, 2018 Filed Sep 4, 2018 21:26 UTC |
GLENN JOHNChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001209191-18-049259 · doc4.xml · derivative · entry 1 GLENN JOHN · CIK 0001253497 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2028-08-31 F1 · derivative.exercise_date: The option becomes exercisable as to 25% of the total number of shares on August 31, 2019 and thereafter vests in equal monthly installments for 36 months. Read SEC document |
| August 06, 2018 Filed Aug 7, 2018 19:43 UTC |
Peurach JackDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 750,000 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001209191-18-045656 · doc4.xml · derivative · entry 2 Peurach Jack · CIK 0001640206 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2028-08-06 F1 · derivative.exercise_date: The option becomes exercisable as to 25% of the total number of shares on March 9, 2019 and thereafter vests in equal monthly installments for 36 months. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 21:05 UTC |
Wang Theodore TDirector · 10% owner
Puissance Capital Fund (GP) LLC10% owner
Puissance Capital Management LP10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 41,000 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001209191-18-045772 · doc4.xml · derivative · entry 3 Wang Theodore T · CIK 0001694061 · Director · 10% owner Puissance Cross-Border Opportunities II LLC · CIK 0001717781 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,000 Underlying: Common Stock · 41,000 shares Expires 2028-08-03 F2 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of June 7, 2018. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 21:05 UTC |
Wang Theodore TDirector · 10% owner
Puissance Capital Fund (GP) LLC10% owner
Puissance Capital Management LP10% owner
|
GrantCommon Stock | 19,179 | $1.79 | $34,330.41 |
DisclosureSEC source: 0001209191-18-045772 · doc4.xml · nonDerivative · entry 1 Wang Theodore T · CIK 0001694061 · Director · 10% owner Puissance Cross-Border Opportunities II LLC · CIK 0001717781 · 10% owner Puissance Capital Fund (GP) LLC · CIK 0001695347 · 10% owner Puissance Capital Management LP · CIK 0001658437 · 10% owner Puissance Capital Management (GP) LLC · CIK 0001695339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,179 Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:55 UTC |
Stern StanleyDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 41,000 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001209191-18-045770 · doc4.xml · derivative · entry 1 Stern Stanley · CIK 0001316499 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,000 Underlying: Common Stock · 41,000 shares Expires 2028-08-03 F1 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of June 7, 2018. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:54 UTC |
SHERMAN STEVENDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 41,000 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001209191-18-045769 · doc4.xml · derivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,000 Underlying: Common Stock · 41,000 shares Expires 2028-08-03 F1 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of June 7, 2018. Read SEC document |
| August 03, 2018 Filed Aug 8, 2018 00:56 UTC |
Li KechengDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 41,000 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001209191-18-045771 · doc4.xml · derivative · entry 1 Li Kecheng · CIK 0001735083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,000 Underlying: Common Stock · 41,000 shares Expires 2028-08-03 F1 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of June 7, 2018. Read SEC document |
| August 03, 2018 Filed Aug 8, 2018 00:54 UTC |
Hamilton MarilynDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 41,000 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001209191-18-045768 · doc4.xml · derivative · entry 1 Hamilton Marilyn · CIK 0001640203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,000 Underlying: Common Stock · 41,000 shares Expires 2028-08-03 F1 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of June 7, 2018. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 19:43 UTC |
Peurach JackDirector · Chief Executive Officer
|
GrantCommon Stock | 11,333 | $1.79 | $20,286.07 |
DisclosureSEC source: 0001209191-18-045656 · doc4.xml · nonDerivative · entry 1 Peurach Jack · CIK 0001640206 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,557 Read SEC document |
| July 13, 2018 Filed Jul 24, 2018 18:04 UTC |
DeLonzor RussChief Operating Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-18-043788 · doc4.xml · derivative · entry 1 DeLonzor Russ · CIK 0001694985 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2028-07-13 F1 · derivative.exercise_date: The option becomes exercisable as to 25% of the total number of shares on the one year anniversary of the date of grant and thereafter vests in equal monthly installments for 36 months. Read SEC document |
| May 23, 2018 Filed May 25, 2018 17:07 UTC |
SHERMAN STEVENDirector
|
PurchaseCommon Stock | 100,000 | $1.52 | $151,560.00 |
DisclosureSEC source: 0001209191-18-033564 · doc4.xml · nonDerivative · entry 2 SHERMAN STEVEN · CIK 0001201619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,825 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.53, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| May 23, 2018 Filed May 25, 2018 17:07 UTC |
SHERMAN STEVENDirector
|
PurchaseCommon Stock | 100,000 | $1.50 | $149,990.00 |
DisclosureSEC source: 0001209191-18-033564 · doc4.xml · nonDerivative · entry 1 SHERMAN STEVEN · CIK 0001201619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,825 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.46 to $1.53, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · balance_after: This number reflects the 1-for-7 reverse stock split that occurred on May 4, 2016. Read SEC document |
| May 10, 2018 Filed Jun 8, 2018 16:33 UTC |
DeLonzor RussVice Pres., Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036700 · doc4.xml · derivative · entry 3 DeLonzor Russ · CIK 0001694985 · Vice Pres., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,437 Underlying: Common Stock · 2,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| May 10, 2018 Filed Jun 8, 2018 16:33 UTC |
DeLonzor RussVice Pres., Operations
|
Tax withholdingCommon Stock | 1,270 | $1.51 | $1,911.60 |
DisclosureSEC source: 0001209191-18-036700 · doc4.xml · nonDerivative · entry 2 DeLonzor Russ · CIK 0001694985 · Vice Pres., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,512 Read SEC document |
| May 10, 2018 Filed Jun 8, 2018 16:33 UTC |
DeLonzor RussVice Pres., Operations
|
Exercise / conversionCommon Stock | 2,813 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-036700 · doc4.xml · nonDerivative · entry 1 DeLonzor Russ · CIK 0001694985 · Vice Pres., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock. Read SEC document |
| May 10, 2018 Filed Jun 8, 2018 16:29 UTC |
SCHEDER-BIESCHIN MAXChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036693 · doc4.xml · derivative · entry 3 SCHEDER-BIESCHIN MAX · CIK 0001342549 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,750 Underlying: Common Stock · 9,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| May 10, 2018 Filed Jun 8, 2018 16:29 UTC |
SCHEDER-BIESCHIN MAXChief Financial Officer
|
Tax withholdingCommon Stock | 4,151 | $1.51 | $6,248.09 |
DisclosureSEC source: 0001209191-18-036693 · doc4.xml · nonDerivative · entry 2 SCHEDER-BIESCHIN MAX · CIK 0001342549 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,959 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.